GlassScriptPhysician profile
John J Kim
NPI 1841252285
$3,877.86
in general payments reported to CMS, 2019-2025
9 companies · $20.74 in 2025
The $20.74 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,159 · 2020: $328 · 2021: $514 · 2022: $389 · 2023: $1,163 · 2024: $304 · 2025: $20.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $937 · Travel and Lodging: $551.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $936.97 |
| Travel and Lodging | $550.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,910.78 | 2019-2023 | Inbone, Prostep, Citrefix |
| In2bones USA, LLC | $848.20 | 2020-2022 | |
| Linvatec Corporation | $542.80 | 2023-2024 | 5ms, Biobrace 23mm, Allograft Tissue |
| Ossio INC | $155.30 | 2022 | |
| Sanara Medtech INC. | $149.30 | 2023 | Celleraterx |
| Medtronic, INC. | $126.26 | 2024-2025 | Inceptiv |
| Organogenesis INC. | $101.63 | 2019 | |
| Lifenet Health | $23.35 | 2023 | |
| Integra Lifesciences Corporation | $20.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.